Varicose Veins Treatment Devices Market Size, Share, Growth, and Industry Analysis, By Type (Laser Ablation Devices and Radiofrequency Ablation Devices), By Application (Hospitals, Clinics and Others), and Regional Forecast From 2026 to 2035

•   
•   
  

  Download Free Sample to learn more about this report

    

VARICOSE VEINS TREATMENT DEVICES MARKET OVERVIEW

The global Varicose Veins Treatment Devices Market is estimated to be valued at USD 1.08 Billion in 2026. The market is projected to reach USD 1.62 Billion by 2035, expanding at a CAGR of  3.6% from 2026 to 2035.Varicose Veins Treatment Devices Market: North America dominates (~50%), Europe (~30%), Asia-Pacific (~15%), driven by minimally invasive vascular treatments.

The varicose veins treatment devices market is gradually growing due to the increased preference for non-invasive or less invasive varieties of treatments. Increasing incidence of chronic venous disease worldwide, resulting from sedentary lifestyle, obesity, growing geriatric population, and extended hours of standing or sitting is the major factor fueling the demand for novel therapeutics technologies. With shorter recovery times, less post-procedure complications, and better comfort to the patient, endovenous laser ablation (EVLA), radiofrequency ablation (RFA), and sclerotherapy delivery systems have gained significant popularity. Health care providers are also trending toward outpatient and ambulatory surgical centers, which creates a further demand for small, easy-to-use, and effective treatment devices.

Moreover, the constant product development in device design and growing awareness about early diagnosis and treatment are contributing to the market growth in developed as well as developing regions. The manufacturers are also focusing on precision-based devices and enhanced catheter designs, and energy-based systems providing better procedural outcomes. Growth of medical tourism for cosmetic and aesthetic vein procedures is also aiding in market growth. With the improvement in healthcare facilities and reimbursement schemes for machinery in the major market, demand for the machinery for varicose veins treatment is poised to pick up pace thereby intensifying the competition among the manufacturers and driving them towards more and more innovations.

COVID-19 IMPACT

Varicose Veins Treatment Devices Industry Had a Negative Effect Due to widespread suspension of elective and non-urgent medical procedures during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

The varicose veins treatment devices market witnessed a significant impact by the COVID-19 pandemic, as the delivery of elective and non-urgent medical procedures came to a halt worldwide. Hospitals diverted resources to emergency and infectious care, causing vein treatments to be delayed or cancelled, and device demand slowed temporarily. A significant number of patients stayed away from health care facilities due to concerns about catching an infection, leading to even fewer procedures being performed and causing revenue streams for both device makers and clinics to dry up. This disturbance also caused delays in the supply chain, particularly for parts used in energy-based ablation systems as well as disposable catheters.

But the market started to recover as restrictions were lifted and providers saw backlog cases as well as patients who were more willing to go under the knife for less-invasive operations. The pandemic also sped up the migration to the outpatient and ambulatory site of services – the common setting for varicose veins treatments – increasing demand for mobile, easy-to-use treatment platforms. Enhanced focus on personal health and preventive care resulted into increased number of patients seeking early care for venous disorders in post pandemic. With the expansion of telehealth visits and digital diagnostics, patient engagement was better, resulting in a stronger bounce back in treatment demand. In general, although the COVID-19 pandemic led to temporary disruptions, it further highlighted the demand for advanced, minimally invasive varicose veins treatment solutions.

LATEST TRENDS

Rising Adoption of Minimally Invasive and Energy-Based Procedure to Drive Market Growth

The varicose veins treatment instruments market is observing an increasing inclination for energy-based and minimally invasive techniques for a quicker recovery and enhanced patient comfort. Endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) has gained popularity over conventional surgical vein stripping because of potential for fewer complications, shorter procedure time and ability to perform as an outpatient. Another major development is the introduction of ‘ultrasound-guided’ catheter systems which help to increase procedural precision and clinical outcomes. In addition, the firms are developing portable, easy-to-use devices that can be utilized in small clinics as well as in ambulatory surgical centers. The increasing popularity of combination therapy approaches where sclerotherapy, foam injection, and ablation techniques are combined to manage complex vein disease is a noteworthy emerging trend. In addition, digital solutions such as teleconsultation, preoperative vein mapping, and artificial intelligence (AI)-enabled diagnostics are enhancing patient engagement and treatment planning. Increased awareness regarding cosmetic and aesthetic outcomes along with the trend of preventive care are some of the other driving factors for the adoption of advanced devices for the treatment of varicose veins on a global scale.

•   
•   
  

  Download Free Sample to learn more about this report

    

VARICOSE VEINS TREATMENT DEVICES MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into laser ablation devices and radiofrequency ablation devices

• Laser Ablation Devices: Laser ablation devices are now commonly used for minimally invasive treatment of varicose veins, which ensures accurate vein closure with less pain and quicker recovery. They are the instrument of choice for use both in cosmetic and clinical applications because of high procedural efficacy with minimal complications. Continuous innovations like enhanced fiber geometries and energy delivery systems are paving the way to better treatment results.

• Radiofrequency Ablation Devices: Radiofrequency ablation devices deliver controlled thermal energy to safely and effectively close the diseased veins. They are being used more and more in the outpatient and hospital setting because of the shorter procedure times, decreased post-operative pain and ability to be used with ultrasound guidance. Increasing clinical preference of RFA can be attributed to predictable outcomes, patient safety and its application to intricate vein anatomy.

By Application

Based on application, the global market can be categorized into hospitals, clinics and others

• Hospitals: Hospitals continue to be a key application segment as they have the capabilities to conduct complex vein procedures along with a high number of patients. The presence of dedicated operating rooms and trained personnel is a key enabler for use of laser and radio frequency ablation systems.

• Clinics: Clinics, especially those that are outpatient and ambulatory, have begun to incorporate varicose veins treatment devices for accomplishing a minimal invasive procedure in a timelier manner. Their ability to offer treatments in a caring environment and at a much lower price point draw people from miles around for cosmetic and preventive care to the veins.

• Others: Other applications include specialized vascular centers, cosmetic surgery centers, & mobile health units for focused treatment on varicose veins. These segments profit from small, portable devices which provide versatility in deployment and enable access to a wide range of medical environments.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.            

Driving Factors

Rising Prevalence of Chronic Venous Disorders to Boost the Market

Rising incidence of chronic venous diseases worldwide, such as varicose veins, chronic venous insufficiency, and spider veins is one of the key factors driving the varicose veins treatment devices market growth. Sedentary lifestyles, an aging population, obesity, and long durations of standing or sitting are causing rates of occurrence to rise, driving demand for therapeutically efficient solutions. Patients along with their physicians have a desire for minimally invasive treatments that offer less risk of procedural complications and long-term recurrence. Laser ablation and radiofrequency ablation apparatus owing to high success rates and outpatient usability are expected to hold significant market share. Moreover, increasing awareness about cosmetic and aesthetical benefits of vein treatments is driving more people to seek early treatment options. Providers are responding by purchasing new equipment and training staff members to deliver energy-based treatments. Increasing patient base and propensity to prefer minimally invasive treatment options are gaining momentum across the globe driving the market growth and making manufacturers to bring innovate solutions in terms of device's efficiency, safety and ease of use.

Technological Advancements in Minimally Invasive Treatments to Expand the Market

Innovation in varicose veins treatment devices is one of the key factors driving the market growth. Improvements in laser fiber technology, energy delivery systems and catheter design have enhanced procedural accuracy, decreased complications, and allowed for a more rapid recovery, bringing these treatments closer to the patients and health care providers. Radiofrequency ablation systems provide controlled thermal energy and ultrasound guidance navigation for complex vein anatomies, increasing safety and effectiveness. The incorporation of digital technologies such as AI-assisted vein mapping and teleconsultation solutions is simplifying preoperative planning and post-procedure care, broadening adoption in hospitals, clinics, and specialty centers. The compact, portable and easy to use design of these devices, are enabling ambulatory surgical centers to provide high quality care without the need for extensive infrastructure. Additionally, the expanding trend of therapy combinations, for example, foam sclerotherapy and energy-based ablation, is growing the spectrum of treatable cases. These ongoing innovations are accelerating provider capabilities to drive superior outcomes, and the market is growing for driven higher procedure volumes and patient acceptance worldwide.

Restraining Factor

High Device Costs and Limited Reimbursement to Potentially Impede Market Growth

The varicose veins treatment devices are expensive, which acts as a major restraint for the market growth. These technologies involve a significant upfront cost for hospitals, clinics and specialty centers, which could hinder adoption, particularly for smaller providers or in developing markets. Furthermore, the cost of procedure, which includes consumables such as catheters, fibers and even energy delivery accessory devices, can be considerably high as compared to traditional surgical procedures, which may discourage patients to undergo the treatment. Limited reimbursement policies across numerous regions acts as a further challenge in hindering the market growth owing to the fact that minimally invasive vein treatment is not often covered, or inconsistently covered, by insurance. Patients may have to incur out-of-pocket costs, which could negatively affect the demand in low and middle-income countries. In addition, the requirement of trained specialists and clinical know-how for managing these devices increases operational challenges. Together they are preventing widespread adoption, especially in developing countries and smaller clinics, hampering the market’s overall growth potential, even with increasing awareness and incidence of venous disorders.

Expansion of Minimally Invasive and Outpatient Treatment Adoption To Create Opportunity for the Product in the Market

Opportunity

A prominent opportunity in the varicose veins treatment devices market is the increasing adoption of minimally invasive and outpatient procedures. Treatments with shortened recovery time, less post-procedural pain, and less scarring are gaining patient preference, resulting in growing demand for laser ablation, radiofrequency ablation, combination therapy and others systems. The movement to ambulatory surgical centers and physician office-based clinics facilitates delivery of care without dependence on the large hospital infrastructure, enhancing access, and facilitating cost efficient operation.

Growing awareness about the cosmetic and aesthetic advantages of varicose vein treatment also paves the way for varicose veins clinics focusing on preventive care and non-invasive treatments. Technology advancements such as portable and easy-to-use devices, ultrasound-guided catheters, and AI-based diagnostic solutions continue to increase procedural accuracy and patient outcomes. Furthermore, surge in medical tourism for beauty and vein treatments in regions such as Europe, North America and Asia is contributing to the potential avenues for the manufacturers. Such trends also grant manufacturers and providers an opportunity to build higher volume procedure focused solutions, and gain greater market penetration across global markets.

Limited Awareness and Procedural Adoption Barriers Could Be a Potential Challenge for Consumers

Challenge

One of the major factors restraining the growth of the varicose veins treatment devices market is the lack of awareness among GPs and patients regarding advanced minimally invasive treatment options. Many people are still not educated about newer treatments such as laser ablation or radiofrequency ablation and continue to use traditional surgical vein stripping, hindering device uptake. In addition, some healthcare providers, particularly in small clinics or developing markets may have insufficient number of trained specialists and lack of technical knowhow required to safely operate high-end equipment, which may present operational hurdle.

The high initial investment required for devices and related consumables, along with uncertain reimbursement policies in different countries, impedes the growth of the market. Procedure fear resulting from its associated risks, patient discomfort, or insufficient insurance coverage may contribute in postponing treatment. Seasonal variations in patient volume and unpredictable procedure numbers also impact return on investment for clinics and hospitals. These combined challenges dampen demand for their widespread use and call for constant physician training efforts, awareness campaigns and cost-optimization measures by manufacturers to propel long-term growth in the varicose veins treatment devices market.

•   
•   
  Download Free Sample to learn more about this report

    

VARICOSE VEINS TREATMENT DEVICES MARKET REGIONAL INSIGHTS

• North America

North America leads the market, with the United States varicose veins treatment devices market growing due to high prevalence of chronic venous disorders and rising patient preference for minimally invasive procedures. Hospitals and clinics are increasingly adopting laser ablation and radiofrequency ablation systems to meet demand for faster recovery and reduced procedural complications. Supportive reimbursement policies, technological advancements, and a focus on outpatient care further drive market growth. Additionally, rising awareness of cosmetic benefits encourages early intervention, while medical tourism within the region contributes to increased procedure volumes, reinforcing North America’s dominant market position.

• Europe

Europe holds a significant varicose veins treatment devices market share due to advanced healthcare infrastructure, well-established vascular surgery centers, and strong adoption of minimally invasive procedures. Countries such as Germany, France, and the United Kingdom are leading in device adoption, supported by favorable reimbursement schemes and growing patient awareness. Expansion of outpatient clinics, cosmetic vein treatment centers, and integration of ultrasound-guided systems continues to enhance the region’s market share. Increasing medical tourism for aesthetic vein treatments further bolsters demand, particularly in Western Europe.

• Asia

Asia is witnessing a growing varicose veins treatment devices market share, driven by urbanization, rising healthcare expenditures, and increasing lifestyle-related venous disorders. China, India, and Japan are emerging as key markets with rising adoption of energy-based minimally invasive therapies in hospitals and specialized clinics. Technological innovations, portable devices for smaller centers, and government initiatives to improve healthcare access contribute to market growth. Additionally, awareness campaigns and increasing disposable income are enabling patients to seek elective and cosmetic vein treatments, further enhancing the region’s market share.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key industry players in the varicose veins treatment devices market are actively focusing on technological innovation, strategic collaborations, and market expansion to strengthen their presence. Companies are developing advanced laser ablation and radiofrequency ablation systems with improved energy delivery, catheter design, and ultrasound-guided capabilities to enhance procedural precision and patient safety. Efforts also include producing portable and user-friendly devices suitable for outpatient clinics and ambulatory surgical centers, expanding access to minimally invasive treatments. Several players are partnering with hospitals, specialty clinics, and medical training institutes to provide hands-on training, clinical support, and awareness programs for physicians. Investments in R&D are aimed at combination therapies, improved consumables, and energy-efficient devices that reduce procedural time and improve patient comfort. Additionally, manufacturers are exploring new markets in Asia, Europe, and North America, while emphasizing digital tools such as AI-assisted diagnostics and teleconsultation platforms to increase patient engagement and streamline treatment planning, ultimately driving adoption and competitive differentiation.

List Of Top Varicose Veins Treatment Devices Companies

• AngioDynamics (United States)
• Lumenis (Israel)
• Medtronic (United States)
• Syneron Medical (Israel)
• Biolitec (Germany)
• Energist Group (United Kingdom)
• Dornier MedTech (Germany)
• Eufoton SRL (Italy)
• Teleflex – Vascular Solutions (United States)
• El.En Group (Italy)
• WON TECH Co., Ltd (South Korea)
• LSO Medical (United States)
• Fosun Pharma (China)
• VVT Med (Germany)
• F Care Systems (France)

KEY INDUSTRY DEVELOPMENT

October 2024: Medtronic (United States) launched an upgraded radiofrequency ablation system for varicose veins, featuring improved catheter flexibility, real-time temperature monitoring, and energy-efficient delivery. The device allows safer and more precise treatment of complex vein anatomies, supporting faster recovery in outpatient and hospital settings. This innovation strengthens Medtronic’s market position and reflects growing demand for minimally invasive, patient-centric vein treatment solutions.

REPORT COVERAGE

This report provides a comprehensive analysis of the varicose veins treatment devices market, covering market dynamics, key growth drivers, restraining factors, opportunities, and challenges. It includes segmentation by type—laser ablation devices and radiofrequency ablation devices—and by application, including hospitals, clinics, and other healthcare settings. The study evaluates technological advancements, procedural trends, and adoption patterns across major regions, highlighting United States varicose veins treatment devices market growth and varicose veins treatment devices market share in Europe and Asia.

Additionally, the report details key industry player efforts, including R&D, product launches, and strategic collaborations, alongside recent industrial developments with month and year. Regional insights, competitive landscape, and emerging trends such as outpatient procedures, portable devices, and AI-assisted diagnostics are also covered. The report provides actionable intelligence for manufacturers, healthcare providers, and investors to make informed decisions, assess market opportunities, and understand future growth potential in the global varicose veins treatment devices market.